Clinical Trials in Changwon, South Korea
Locations / Changwon, South Korea
Delta Trials records 113 clinical trials conducted in Changwon, South Korea, making it a notable site of clinical research activity. These trials across 164 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Changwon has changed over time.
113
Total Trials
164
Conditions
1
Terminated since 2020
Browse by condition (164 total)
- Coronary artery disease 12 trialsAll Coronary artery disease trials
- Heart failure 4 trialsAll Heart failure trials
- Gastric cancer 4 trialsAll Gastric cancer trials
- Alzheimer's disease 4 trialsAll Alzheimer's disease trials
- Coronary disease 3 trialsAll Coronary disease trials
- Atrial fibrillation 3 trialsAll Atrial fibrillation trials
- Myocardial ischemia 3 trialsAll Myocardial ischemia trials
- Acute coronary syndrome 3 trialsAll Acute coronary syndrome trials
- Hypertension 2 trialsAll Hypertension trials
- Breast cancer 2 trialsAll Breast cancer trials
- All Extensively drug-resistant tuberculosis trials
- Hepatitis c virus 2 trialsAll Hepatitis c virus trials
- Endometrial cancer 2 trialsAll Endometrial cancer trials
- Alzheimer's disease 2 trialsAll Alzheimer's disease trials
- Early gastric cancer 2 trialsAll Early gastric cancer trials
- Percutaneous coronary intervention 2 trialsAll Percutaneous coronary intervention trials
- Cardiovascular diseases 2 trialsAll Cardiovascular diseases trials
- Atrioventricular block 2 trialsAll Atrioventricular block trials
- Influenza 2 trialsAll Influenza trials
- Diphtheria 2 trialsAll Diphtheria trials